Biotech Startups
9,920 companies tagged Biotech, with their investors and founders.
Infinimmune discovers and develops antibody therapeutics using proprietary sequencing technology and AI-powered optimization. The company serves pharmaceutical and biotech partners developing treatments across 350+ disease targets.
2 investors
Infiniplex is a precision oncology company developing InfiniplexDX, a liquid biopsy platform that uses proprietary primer design and molecular-switch chemistry with software-based signal analysis to detect cancer mutations in blood and urine on standard PCR instruments. It targets five clinical indications (bladder cancer, myelodysplastic syndromes, pancreatic, colorectal, and non-small cell lung cancer) to support treatment decisions without tissue biopsies.
2 investors
Infinity Bio provides immune system analysis through its proprietary MIPSA antibody reactome profiling platform, which identifies the targets of individual immune responses against human viruses, human proteins (autoimmunity), and allergen proteins. The technology, developed at Johns Hopkins University's Laboratory of Precision Immunology, is used for immunology and diagnostics research.
2 investors
Inflammatix develops host-response-based molecular diagnostics tests to identify acute infections and sepsis in emergency and critical care settings. The company's diagnostic platform serves healthcare providers treating acutely ill patients, with applications extending to emerging infectious diseases, autoimmune conditions, and transplant rejection.
2 investors
Inflow is an app-based program providing personalized coaching, strategies, and tools to help people with ADHD manage their condition. The platform combines clinical guidance from psychology experts with a supportive community, designed to make mental health support affordable and accessible for neurodiverse individuals.
2 investors
Inhalon Biopharma is a clinical-stage biotechnology company developing inhaled "muco-trapping" antibody treatments for acute respiratory infections, including RSV, influenza, human metapneumovirus, and SARS-CoV-2. Its therapies aim to treat active infection directly in the lung.
2 investors
Inherent Biosciences develops clinical diagnostic solutions using epigenetics and AI to address complex healthcare concerns. The company is built by a team of molecular biologists, data scientists, and healthcare providers.
2 investors
Inipharm is a clinical-stage biopharmaceutical company developing small-molecule inhibitors targeting HSD17B13 to treat severe fibrotic liver diseases, including MASH and other conditions with established genetic validation.
2 investors
ImageneBio is a clinical-stage biotechnology company developing therapeutics for patients with immunological, autoimmune, and inflammatory diseases. The company leverages its management team's extensive experience in drug development and commercialization across all stages.
2 investors
Neonatal care technology developer for preterm and full-term infants.
2 investors
Innerspace is a health-tech company that helps pharmaceutical companies improve quality, efficiency, and compliance in aseptic manufacturing. Its Frame-by-Frame methodology captures industry knowledge to power data-driven digital solutions for process optimization, risk assessment, and training, including virtual reality-based cleanroom training.
2 investors
Dec Group provides end-to-end process technologies and equipment for powder handling, containment, and continuous manufacturing serving the pharmaceutical and chemical processing industries. The company operates internationally, with subsidiaries including Dec Continuous Process Ltd and Dec Brasil serving customers across Europe, South America, and beyond.
2 investors
Innocent Meat develops an automated cultured meat production system that enables conventional meat processors to manufacture lab-grown minced meat in-house using AI-controlled bioreactors, with integrated supply chain support for biological ingredients. The plug-and-play solution requires minimal space and specialized knowledge, targeting existing meat factories seeking to reduce animal agriculture reliance.
2 investors
Inocras is a bioinformatics company that uses whole genome sequencing and proprietary analytics to produce clinically actionable insights for patient diagnosis and treatment, operating a CLIA-certified and CAP-accredited lab. It serves patients, clinicians, and researchers with whole genome diagnostic testing, sequencing and interpretation services, genetic counseling, and clinical trial matching.
2 investors
InsideTracker provides personalized health insights by analyzing biological markers and genetic data to deliver customized recommendations for nutrition, fitness, and lifestyle optimization for individuals seeking longevity and preventive wellness.
2 investors
InSpek develops integrated photonic sensing technologies for chemical detection applications, translating chip-scale spectroscopic techniques from research into commercial deployment.
2 investors
Instapath develops rapid digital pathology microscopy platforms that enable cancer diagnosis from tissue samples in minutes rather than days. The technology serves pathology labs and healthcare providers to accelerate cancer diagnosis and reduce repeat biopsy procedures.
2 investors
Instil Bio is a biotechnology company that identifies and develops therapeutic opportunities.
2 investors
Intact Therapeutics develops next-generation biopharmaceutical therapies for gastrointestinal diseases to address unmet clinical needs. The company is clinical-stage and focused on improving patient outcomes through innovative medicines.
2 investors
Commercializing rapid DNA analysis technology for forensics; acquired by Thermo Fisher Scientific in 2018.
2 investors
Integrated Biometrics designs and manufactures biometric identification hardware and software, including fingerprint sensors and touchless identification SDKs for law enforcement, border security, government identity systems, and commercial applications across 120+ countries.
2 investors
Integrated Biosciences is a biotech company developing small molecule therapeutics for age-related diseases, using optogenetics, chemistry, and AI to study aging biology. It operates an integrated drug discovery platform combining synthetic biology, chemical data, and machine learning.
2 investors
Interface Bio develops immunotherapies targeting complex inflammatory diseases by combining biological evolution, metabolomics, and machine learning to discover natural-derived therapeutic products.
2 investors
2 investors